Arjay doesn't need to elaborate on this thesis, respectfully they are wrong. You don't need to start producing revenue to see substantial SP gains. I literally analysed Neuren Pharmaceuticals (NEU) about ten posts above which proves this. They didn't start producing income until 2022 FY and yet reached an SP of $3!
PER - Megathread, page-356
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.002(1.88%) |
Mkt cap ! $70.32M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.6¢ | $9.333K | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 112759 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 104192 | 6 |
View Market Depth
| Last trade - 15.56pm 13/08/2024 (20 minute delay) ? |
| PER (ASX) Chart |